RxDoctor Payments Data

Madeline Gresham

Women's Health · Pekin, ILNPI 1124748009

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $1,685 and has fallen 75.9% since, to $406 in 2025. Among women's health clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,300in general payments, 2019–2025

Across 27 payments — averaging $85.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Astellas Pharma US Inc$196
  • Amgen$149
  • Organon$102
  • Axonics, Inc.$82
  • Bayer$47
  • plus $125 from 6 others

What the payments were for

  • Travel & lodging$1,26255%
  • Food & beverage$96842%
  • Education$703%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,300 in reported general payments places this provider in the 90th percentile of 182 women's health providers in Illinois.

See all women's health providers in Illinois

Medicare billing

Part B allowed, 2024
$2,774
Medicare patients
23
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol53$2,827
Estradiol (Twice Weekly)Estradiol13$817
Norethindrone29$501
ProgesteroneProgesterone, Micronized21$411
Clobetasol Propionate11$243
Junel FeNorethindrone-E.Estradiol-Iron13$205

Paid to pharmacies, not to this prescriber.

Other women's health in Pekin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →